Global X Genomics & Biotechnology ETF
GNOM
43 hedge funds and large institutions have $11.7M invested in Global X Genomics & Biotechnology ETF in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 14 closing their positions.
17.15% more ownership
Funds ownership: 6.99% → 24.14% (+17%)
6% less capital invested
Capital invested by funds: $12.4M → $11.7M (-$753K)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
19% less funds holding
Funds holding: 53 → 43 (-10)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$251K |
| 2 |
CFD
Creative Financial Designs
Kokomo,
Indiana
|
+$220K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$193K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$126K |
| 5 |
Rockefeller Capital Management
New York
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$956K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$497K |
| 3 |
AA
Armis Advisers
Atlanta,
Georgia
|
-$432K |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
-$238K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$198K |
GNOM Hedge Fund Activity: Q3 2025 in Review
43 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2025, worth a combined $11.7M — down 6.1% from $12.4M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of GNOM and 4 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 16 added.
The largest buyer was Jane Street, adding an estimated $251K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $956K sold.
- 43 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2025, down from 53 in Q2 2025.
- Funds reported $11.7M of Global X Genomics & Biotechnology ETF stock for Q3 2025, down 6.1% quarter-over-quarter.
- 4 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2025 and 14 closed out, a net change of -10 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2025 was Jane Street, an estimated $251K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2025 was Two Sigma Investments, an estimated $956K sold.
Based on aggregated 13F filings for Q3 2025.